Table 4.
Pathologic findings for 103 patients undergoing total pancreatectomy
| Variable | Overall (n = 103) | LTP (n = 24) |
| Malignant | n = 53 | n = 12 |
| Pancreatic ductal adenocarcinoma | 42 (40.8%) | 5 (20.8%) |
| De novo | 23 (22.3%) | 3 (12.5%) |
| Arising from IPMN | 19 (18.5%) | 2 (8.3%) |
| Neuroendocrine | 7 (6.8%) | 6 (25%) |
| Cholangiocarcinoma with IPMN | 1 (0.97%) | 0 |
| Ampullary adenocarcinoma with IPMN | 1 (0.97%) | 1 (4.2%) |
| Renal cell carcinoma | 1 (0.97%) | 0 |
| Sarcoma | 1 (0.97%) | 0 |
| Tumor size, cm1 | 3.5 ± 2.4 (0.5%-14%) | 3.2 ± 2.5 (1.3%-10%) |
| Margin negative (R0) | 41 (77.4%) | 11 (91.7%) |
| Number of lymph nodes harvested1 | 23 ± 14 (1%-61%) | 28 ± 11 (11%-41%) |
| Non malignant | n = 50 | n = 12 |
| IPMN | 40 (38.8%) | 11 (45.8%) |
| Chronic pancreatitis | 8 (7.8%) | 1 (4.2%) |
| Ampullary adenoma with IPMN | 1 (0.97%) | 0 |
| Trauma | 1 (0.97%) | 0 |
1
Values are mean (range), values in parenthesis are percentages unless otherwise indicated. IPMN: Intraductal papillary mucinous neoplasm; LTP: Laparoscopic total pancreatectomy.